Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flurbiprofen ester timing for pain prevention after breast cancer surgery
ChiCTR1900024770Phase 4Recruiting
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Start
- Jul 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of flurbiprofen axetil in postoperative pain and chronic pain (3 arms), sponsored by Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Primary endpoint: ASA score. Started Jul 2019; status: recruiting.
02
Drugs
flurbiprofen axetil
03
Conditions
postoperative painchronic pain
Beyond the preview
Go deeper on ChiCTR1900024770.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900024770.